|Articles|July 1, 2018
- Pharmaceutical Executive-07-01-2018
- Volume 38
- Issue 7
Pharmaceutical Executive, July 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Opioid Litigation: Evading the Widening Crosshairsalmost 8 years ago
Patient & Customer-Centric Commercializationalmost 8 years ago
Compliance: The Critical Cog in Pharma Machinealmost 8 years ago
Gaining Ground with Stem Cells: Gil Van Bokkelen, Athersysalmost 8 years ago
A Seat at the Strategy Tablealmost 8 years ago
Regulatory Innovation Generates Breakthroughsalmost 8 years ago
China’s Biopharma Rise: Opportunities and ThreatsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
3
Teva Enters $900 Million Agreement to Acquire Emalex
4
How are US Regulatory Actions Impacting Pricing?
5